eng Science and Education Publishing American Journal of Medical Case Reports 2374-216X 2020-03-10 8 5 115 118 10.12691/ajmcr-8-5-2 AJMCR2020852 article Evan Botti MD 1 Michelle Likhtshteyn MD michelle.likhtshteyn@downstate.edu 1 Ghulam Ilyas MD 2 Evan Marzouk 2 Kakin R. Iong MD 2 Internal Medicine, SUNY Downstate Medical Center, Brooklyn, United States Department of Pathology, SUNY Downstate Medical Center, Brooklyn, United States Drug Induced Liver Injury (DILI)accounts for around 11% of all Acute Liver Failure (ALF)cases and are usually associated with over the counter supplements [1]. Hepatotoxicity due to Hydralazine is not commonly reported [2]. Often times DILI may have variable presentations and latency times, making diagnosis difficult. Here we present a 70-year-oldfemale with multiple medical problems who presented to the hospital with jaundice and abdominal pain and concluded to have hydralazine induced liver injury. http://pubs.sciepub.com/ajmcr/8/5/2/ajmcr-8-5-2.pdf DILI hydralazine liver failure transaminitis liver injury